News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
349,124 Results
Type
Article (18320)
Company Profile (306)
Press Release (330492)
Multimedia
Podcasts (80)
Webinars (12)
Section
Business (97170)
Career Advice (189)
Deals (17099)
Drug Delivery (44)
Drug Development (56421)
Employer Resources (35)
FDA (8183)
Job Trends (6124)
News (176168)
Policy (13447)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (1085)
Accelerated approval (21)
Adcomms (14)
Allergies (98)
Alliances (27656)
ALS (129)
Alzheimer's disease (1155)
Antibody-drug conjugate (ADC) (274)
Approvals (8440)
Artificial intelligence (308)
Autoimmune disease (128)
Automation (9)
Bankruptcy (122)
Best Places to Work (5243)
BIOSECURE Act (6)
Biosimilars (122)
Biotechnology (235)
Bladder cancer (106)
Brain cancer (49)
Breast cancer (389)
Cancer (3373)
Cardiovascular disease (413)
Career advice (174)
Career pathing (8)
CAR-T (230)
CDC (6)
Cell therapy (594)
Cervical cancer (15)
Clinical research (48915)
Collaboration (1281)
Company closure (2)
Compensation (638)
Complete response letters (44)
COVID-19 (1255)
CRISPR (88)
C-suite (599)
Cystic fibrosis (112)
Data (4756)
Denatured (15)
Depression (102)
Diabetes (320)
Diagnostics (2102)
Digital health (19)
Diversity (5)
Diversity, equity & inclusion (10)
Drug discovery (205)
Drug pricing (65)
Drug shortages (7)
Duchenne muscular dystrophy (222)
Earnings (38174)
Editorial (27)
Employer branding (5)
Employer resources (33)
Events (58786)
Executive appointments (678)
FDA (10229)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (10)
Frontotemporal dementia (22)
Funding (1061)
Gene editing (186)
Generative AI (23)
Gene therapy (516)
GLP-1 (675)
Government (1417)
Grass and pollen (4)
Guidances (196)
Healthcare (7815)
HIV (21)
Huntington's disease (43)
IgA nephropathy (83)
Immunology and inflammation (200)
Immuno-oncology (45)
Indications (81)
Infectious disease (1384)
Inflammatory bowel disease (163)
Inflation Reduction Act (10)
Influenza (55)
Intellectual property (184)
Interviews (20)
IPO (8479)
IRA (18)
Job creations (1174)
Job search strategy (155)
JPM (43)
Kidney cancer (9)
Labor market (23)
Layoffs (260)
Leadership (10)
Legal (2338)
Liver cancer (53)
Longevity (14)
Lung cancer (462)
Lymphoma (263)
Machine learning (26)
Management (8)
Manufacturing (434)
MASH (147)
Medical device (4639)
Medtech (4656)
Mergers & acquisitions (9350)
Metabolic disorders (909)
Multiple sclerosis (114)
NASH (15)
Neurodegenerative disease (247)
Neuropsychiatric disorders (74)
Neuroscience (2129)
Neurotech (1)
NextGen: Class of 2026 (2299)
Non-profit (1076)
Now hiring (33)
Obesity (430)
Opinion (132)
Ovarian cancer (137)
Pain (110)
Pancreatic cancer (174)
Parkinson's disease (241)
Partnered (14)
Patents (333)
Patient recruitment (381)
Peanut (44)
People (30996)
Pharmaceutical (45)
Pharmacy benefit managers (10)
Phase 1 (16462)
Phase 2 (22129)
Phase 3 (15131)
Pipeline (3739)
Policy (104)
Postmarket research (1298)
Preclinical (6948)
Press Release (32)
Prostate cancer (163)
Psychedelics (50)
Radiopharmaceuticals (249)
Rare diseases (680)
Real estate (2069)
Recruiting (14)
Regulatory (12466)
Reports (22)
Research institute (1125)
Resumes & cover letters (19)
Rett syndrome (24)
RNA editing (21)
RSV (19)
Schizophrenia (130)
Series A (195)
Series B (154)
Service/supplier (1)
Sickle cell disease (79)
Special edition (18)
Spinal muscular atrophy (120)
Sponsored (16)
Startups (2285)
State (1)
Stomach cancer (6)
Supply chain (40)
Tariffs (20)
The Weekly (64)
Vaccines (386)
Venture capital (74)
Weight loss (245)
Women's health (31)
Worklife (2)
Date
Today (10)
Last 7 days (353)
Last 30 days (1258)
Last 365 days (19723)
2026 (2224)
2025 (19997)
2024 (22705)
2023 (25043)
2022 (31850)
2021 (32767)
2020 (28108)
2019 (19852)
2018 (14542)
2017 (16745)
2016 (14951)
2015 (18151)
2014 (13622)
2013 (10337)
2012 (10626)
2011 (10940)
2010 (10617)
Location
Africa (225)
Alabama (66)
Alaska (2)
Arizona (88)
Arkansas (5)
Asia (32170)
Australia (4802)
California (7517)
Canada (2136)
China (946)
Colorado (259)
Connecticut (268)
Delaware (269)
Europe (50657)
Florida (1017)
Georgia (222)
Hawaii (3)
Idaho (17)
Illinois (449)
India (51)
Indiana (188)
Iowa (8)
Japan (377)
Kansas (87)
Kentucky (11)
Louisiana (10)
Maine (13)
Maryland (825)
Massachusetts (5981)
Michigan (117)
Minnesota (333)
Mississippi (3)
Missouri (40)
Montana (16)
Nebraska (6)
Nevada (48)
New Hampshire (22)
New Jersey (1981)
New Mexico (14)
New York (1932)
North Carolina (947)
North Dakota (6)
Northern California (3717)
Ohio (191)
Oklahoma (11)
Oregon (25)
Pennsylvania (1347)
Puerto Rico (10)
Rhode Island (27)
South America (320)
South Carolina (16)
Southern California (2950)
Tennessee (52)
Texas (966)
United States (25487)
Utah (119)
Virginia (146)
Washington D.C. (42)
Washington State (614)
West Virginia (2)
Wisconsin (51)
349,124 Results for "nanoform cardiovascular therapeutics ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lexeo Therapeutics Announces Key Leadership Appointments Strengthening Cardiovascular Expertise Alongside Updates to Strategic Partnership for Novel Cardiac RNA Therapeutics
January 28, 2026
·
7 min read
Cardiovascular disease
Amgen, Merck, Novo, More Take Cardiovascular Benefits to New Heights at AHA 2025
Data presented at this year’s American Heart Association Scientific Sessions in New Orleans underline rapid advancements in the cardiovascular field.
November 11, 2025
·
5 min read
·
Tristan Manalac
Approvals
Novo Secures Cardiovascular Expansion for Semaglutide Pill
Rybelsus can now be used as a primary or secondary prevention pill to lower the risk of major adverse cardiovascular events in at-risk patients with type 2 diabetes.
October 20, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates
December 24, 2025
·
3 min read
Press Releases
Atom Therapeutics Launches Multi-Regional Phase 2 Trial of ABP-745 for Atherosclerotic Cardiovascular Disease (ASCVD)
December 16, 2025
·
4 min read
Press Releases
vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737
February 2, 2026
·
7 min read
Press Releases
Rona Therapeutics Unveils the Global First Bi-valent PCSK9-LPA siRNA into Clinical Development for Cardiovascular Risk Reduction
December 18, 2025
·
2 min read
Press Releases
Tenpoint Therapeutics Ltd. Announces FDA Approval of YUVEZZI™, the First and Only Combination Eye Drop Approved to Treat Presbyopia
January 29, 2026
·
8 min read
Press Releases
AngioDynamics to Convene Cardiovascular Leaders at Scientific Forum as Pipeline Continues to Advance
February 4, 2026
·
9 min read
Press Releases
Medicus Pharma Receives FDA “Study May Proceed” Clearance For Teverelix® Phase 2b Study in Advanced Prostate Cancer Patients with High Cardiovascular Risk
February 10, 2026
·
14 min read
1 of 34,913
Next
